List of products in the National Drug Code with proprietary name . This medication is used to treat plaque psoriasis. Brodalumab belongs to a class of drugs known as monoclonal antibodies. It works by blocking a certain natural protein in your body (interleukin-17A) that may cause inflammation and swelling. Brodalumab treatment may lead to reduced plaque thickness, redness, and scaling.
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Labeler Name | Product Type |
---|---|---|---|---|---|---|
68225-086 | Brodalumab | Injection | Patheon Italia S.p.a. | Drug For Further Processing |